Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis
Open Access
- 9 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (4) , 741-746
- https://doi.org/10.1093/jac/dkl014
Abstract
Objectives: Azithromycin is used to modulate exuberant inflammatory response in patients with cystic fibrosis (CF). The purpose of this study was to determine the association between long-term use of azithromycin in CF patients and change over time in macrolide susceptibility of Staphylococcus aureus and Haemophilus spp. Methods: The study was performed at the Erasmus MC–Sophia Children's Hospital. CF patients' sputum cultures were obtained at routine visits and at pulmonary exacerbations. All cultures between January 1999 and March 2004 were included. Antibiotic susceptibility of S. aureus and Haemophilus spp. was tested routinely. Susceptibility was compared with isolates from sputum of non-CF patients. Logistic regression was used to analyse the association between azithromycin use and resistance, adjusting for age, Pseudomonas carriage and time-trends. Results: In March 2004 one-third of CF patients were on azithromycin maintenance treatment. S. aureus (715 isolates) and/or Haemophilus (537 isolates) were cultured in 141 of the 155 patients on one or more occasions. The study period was divided into octiles. Erythromycin resistance in S. aureus increased from 6.9 to 53.8% and clarithromycin resistance in Haemophilus spp. from 3.7 to 37.5%. Resistance but also isolation rates were strongly related to azithromycin use. Resistance of 3217 S. aureus control isolates remained stable and resistance of 3257 Haemophilus controls increased, although at a slower rate than CF isolates. Conclusions: Over a 4 year period, azithromycin maintenance therapy in our CF population was associated with an increase in macrolide resistance in S. aureus and Haemophilus spp.Keywords
This publication has 14 references indexed in Scilit:
- Immunomodulatory effects of macrolides: Implications for practicing cliniciansThe American Journal of Medicine Supplements, 2004
- Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosisJournal of Antimicrobial Chemotherapy, 2004
- Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosaJAMA, 2003
- Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trialPublished by Elsevier ,2002
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialThorax, 2002
- Lower Airway Inflammation in Infants and Young Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Early Pulmonary Inflammation in Infants with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1995
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995